Patents by Inventor David K. L. Peterson

David K. L. Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10940033
    Abstract: An exemplary method treating an erectile dysfunction condition in a patient includes 1) generating, by an electroacupuncture device implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05, and 2) applying, by the electroacupuncture device in accordance with the duty cycle, the stimulation sessions to a target tissue location within the patient by way of an electrode array located within the patient at an acupoint corresponding to the target tissue location.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: March 9, 2021
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy O. Greiner
  • Publication number: 20210030621
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.
    Type: Application
    Filed: October 21, 2020
    Publication date: February 4, 2021
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Publication number: 20210000687
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: September 23, 2020
    Publication date: January 7, 2021
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Patent number: 10820864
    Abstract: An exemplary method includes determining a variability of a plurality of measurements of a cardiovascular parameter of a patient suffering from hypertension, the plurality of measurements recorded one at a time over a predetermined time period. The method further includes comparing the determined variability with a predetermined reference value. If the comparing indicates that the determined variability is less than the predetermined reference value, the method includes designating the patient to be within a first class of patients representative of patients that are likely to be responsive to subcutaneous neuromodulation therapy as a treatment for hypertension. If the comparing indicates that the determined variability is greater than the predetermined reference value, the method includes designating the patient to be within a second class of patients representative of patients that are likely to be unresponsive to subcutaneous neuromodulation therapy as a treatment for hypertension.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: November 3, 2020
    Assignee: Valencia Technologies Corporation
    Inventor: David K. L. Peterson
  • Publication number: 20200316381
    Abstract: A current generation architecture for an implantable stimulator device such as an Implantable Pulse Generator (IPG) is disclosed. Current source and sink circuitry are both divided into coarse and fine portions, which respectively can provide coarse and fine current resolutions to a specified electrode on the IPG. The coarse portion is distributed across all of the electrodes and so can source or sink current to any of the electrodes. The coarse portion is divided into a plurality of stages, each of which is capable via an associated switch bank of sourcing or sinking a coarse amount of current to or from any one of the electrodes on the device. The fine portion of the current generation circuit preferably includes source and sink circuitry dedicated to each of the electrode on the device, which can comprise digital-to-analog current converters (DACs).
    Type: Application
    Filed: June 17, 2020
    Publication date: October 8, 2020
    Inventors: Jordi Parramon, David K.L. Peterson, Paul J. Griffith
  • Patent number: 10792219
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: October 6, 2020
    Assignee: Valencia Technologies Corporation
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy O. Greiner
  • Patent number: 10744325
    Abstract: A current generation architecture for an implantable stimulator device such as an Implantable Pulse Generator (IPG) is disclosed. Current source and sink circuitry are both divided into coarse and fine portions, which respectively can provide coarse and fine current resolutions to a specified electrode on the IPG. The coarse portion is distributed across all of the electrodes and so can source or sink current to any of the electrodes. The coarse portion is divided into a plurality of stages, each of which is capable via an associated switch bank of sourcing or sinking a coarse amount of current to or from any one of the electrodes on the device. The fine portion of the current generation circuit preferably includes source and sink circuitry dedicated to each of the electrode on the device, which can comprise digital-to-analog current converters (DACs).
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: August 18, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Jordi Parramon, David K. L. Peterson, Paul J. Griffith
  • Patent number: 10744318
    Abstract: Disclosed herein are current output architectures for implantable stimulator devices. Current source and sink circuitry is divided into a plurality of stages, each of which is capable via an associated switch bank of sourcing or sinking an amount of current to or from any one of the electrodes of the device. The current source circuitry is distinct from the current sink circuitry, and the two share no common circuit nodes prior to connection to the electrodes. In other words, the current source circuitry and the current sink circuitry do not share a common node other than the electrodes. Each stage is preferably formed of a current mirror for receiving a reference current and outputting a scaled version of current to that stage's switch bank. The scalar at each stage can be set by wiring a desired number of output transistors in parallel.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: August 18, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Yuping He, David K. L. Peterson
  • Patent number: 10695567
    Abstract: A neurostimulation paddle lead, method of neurostimulation, and neurostimulation system are provided. The neurostimulation paddle lead carries a plurality of electrodes comprising at least four columns of electrodes having a spacing between two inner electrode columns less than a spacing between the inner electrode columns and adjacent outer electrode columns. The inner electrode columns may also be longitudinally offset from the outer electrode columns. The methods and neurostimulation systems steer current between the electrodes to modify a medial-lateral electrical field created adjacent spinal cord tissue.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: June 30, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Dongchul Lee, Kerry Bradley, David K. L. Peterson
  • Patent number: 10675457
    Abstract: A neurostimulation paddle lead, method of neurostimulation, and neurostimulation system are provided. The neurostimulation paddle lead carries a plurality of electrodes comprising at least four columns of electrodes having a spacing between two inner electrode columns less than a spacing between the inner electrode columns and adjacent outer electrode columns. The inner electrode columns may also be longitudinally offset from the outer electrode columns. The methods and neurostimulation systems steer current between the electrodes to modify a medial-lateral electrical field created adjacent spinal cord tissue.
    Type: Grant
    Filed: January 2, 2018
    Date of Patent: June 9, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Dongchul Lee, Kerry Bradley, David K. L. Peterson
  • Publication number: 20200164214
    Abstract: An implantable stimulator includes a housing configured to be implanted beneath a skin surface of a patient and having a first surface adapted to face inwardly into tissue of the patient at or near a target tissue location; pulse generation circuitry located within the housing and electrically coupled to at least two electrodes, the pulse generation circuitry being adapted to deliver stimulation sessions by way of the at least two electrodes to the target tissue location, wherein each stimulation session included in the stimulation sessions has a duration of T3 minutes and a rate of occurrence of once every T4 minutes, wherein a ratio of T3 to T4 is no greater than 0.05; and a primary battery contained within the housing and electrically coupled to the pulse generation circuitry, the primary battery having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: January 30, 2020
    Publication date: May 28, 2020
    Inventors: David K. L. Peterson, Jeffrey H. Greiner
  • Publication number: 20200121913
    Abstract: A method, programmer for a neurostimulator, and neurostimulation kit are provided. The kit comprises a neurostimulator, and a plurality of elongated lead bodies configured for being coupled to the neurostimulator, each having a plurality of proximal contacts and a plurality of distal electrodes respectively electrically coupled to the proximal contacts, wherein an in-line connectivity between the electrodes and proximal contacts carried by the different lead bodies differs from each other. Electrical energy is conveyed between the electrodes of the selected lead body and the tissue, an electrical fingerprint is measured at the proximal contacts of the selected lead body in response to the conveyed electrical energy, and the selected lead body is identified based on the measured electrical fingerprint. These steps can be performed by the programmer.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 23, 2020
    Inventor: David K.L. Peterson
  • Publication number: 20200121917
    Abstract: A method of treating hypertension in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a tissue location associated with the hypertension. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: November 22, 2019
    Publication date: April 23, 2020
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara
  • Patent number: 10576293
    Abstract: An implantable electroacupuncture device for treating a medical condition of a patient through application of electroacupuncture stimulation pulses to a target tissue location within the patient includes 1) a housing configured to be implanted beneath a skin surface of the patient, 2) pulse generation circuitry located within the housing and electrically coupled to at least two electrodes, the pulse generation circuitry being adapted to deliver stimulation sessions by way of the at least two electrodes to the target tissue location in accordance with a stimulation regimen, and 3) a primary battery contained within the housing and electrically coupled to the pulse generation circuitry, the primary battery having an internal impedance greater than 5 ohms and a capacity of less than 60 mAh, wherein the primary battery is the only battery that provides power to the pulse generation circuitry.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: March 3, 2020
    Assignee: Valencia Technologies Corporation
    Inventors: David K. L. Peterson, Jeffrey H. Greiner
  • Publication number: 20200061381
    Abstract: A method of treating osteoarthritis in a knee includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of a patient, stimulation sessions at a duty cycle that is less than 0.05, and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a location that includes at least one of an acupoint labeled ST35, an acupoint labeled EX-LE-4, and a location on a line that intersects the acupoints labeled ST35 and EX-LE-4. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: October 29, 2019
    Publication date: February 27, 2020
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Stacy Greiner Chambliss
  • Patent number: 10549085
    Abstract: A method, programmer for a neurostimulator, and neurostimulation kit are provided. The kit comprises a neurostimulator, and a plurality of elongated lead bodies configured for being coupled to the neurostimulator, each having a plurality of proximal contacts and a plurality of distal electrodes respectively electrically coupled to the proximal contacts, wherein an in-line connectivity between the electrodes and proximal contacts carried by the different lead bodies differs from each other. Electrical energy is conveyed between the electrodes of the selected lead body and the tissue, an electrical fingerprint is measured at the proximal contacts of the selected lead body in response to the conveyed electrical energy, and the selected lead body is identified based on the measured electrical fingerprint. These steps can be performed by the programmer.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: February 4, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: David K. L. Peterson
  • Patent number: 10543362
    Abstract: A method and system of providing therapy to a patient using electrodes implanted adjacent tissue. The method comprises regulating a first voltage at an anode of the electrodes relative to the tissue, regulating a second voltage at a cathode of the electrodes relative to the tissue, and conveying electrical stimulation energy between the anode at the first voltage and the cathode at the second voltage, thereby stimulating the neural tissue. The system comprises a grounding electrode configured for being placed in contact with the tissue, electrical terminals configured for being respectively coupled to the electrodes, a first regulator configured for being electrically coupled between an anode of the electrodes and the grounding electrode, a second regulator configured for being electrically coupled between an anode of the electrodes and the grounding electrode, and control circuitry configured for controlling the regulators to convey electrical stimulation energy between the anode and cathode.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: January 28, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: David K. L. Peterson
  • Publication number: 20200023188
    Abstract: Tissue stimulation systems generally include a pulse generating device for generating electrical stimulation pulses, at least one implanted electrode for delivering the electrical stimulation pulses generated by the pulse generating device, and a programmer capable of communicating with the pulse generating device. Stimulation pulses may be defined by several parameters, such as pulse width and amplitude. In methods of stimulating the tissue with the stimulation system, a user may adjust one of the parameters such as pulse width. The programmer may automatically adjust the pulse amplitude in response to the change in pulse width in order to maintain a substantially constant effect of the stimulation pulses.
    Type: Application
    Filed: September 30, 2019
    Publication date: January 23, 2020
    Inventors: James R. Thacker, Harold Haut, Robert Nathan, David K.L. Peterson, Kerry Bradley
  • Patent number: 10518082
    Abstract: An electroacupuncture device for treating hypertension in a patient includes 1) a housing configured to be implanted beneath a skin surface of the patient at an acupoint corresponding to a target tissue location within the patient, the acupoint comprising at least one of PC5, PC6, ST36, and ST37, 2) a central electrode of a first polarity and centrally located and substantially planar on a first surface of the housing, 3) an annular electrode of a second polarity and that surrounds the central electrode on the first surface of the housing, the annular electrode being spaced apart from the central electrode, and 4) pulse generation circuitry located within the housing and electrically coupled to the annular and central electrodes.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: December 31, 2019
    Assignee: Valencia Technologies Corporation
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara
  • Patent number: 10518089
    Abstract: A method of providing therapy to a patient using a plurality of electrodes is provided. The electrodes are located adjacent a target neural tissue region having a first nerve fiber of a relatively small diameter and a second nerve fiber of a relatively large diameter. The method comprises sourcing electrical current from a local anode into the target neural tissue region. The method further comprises therapeutically sinking a first portion of the electrical current from the target neural tissue region into a local cathode. The method further comprises sinking a second portion of the electrical current into a cathode remote from the target neural tissue region. The ratio of the sourced electrical current over the first sunk electrical current portion has a value that allows the first nerve fiber to be recruited by the electrical current while preventing the second nerve fiber from being recruited by the electrical current.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: December 31, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Dongchul Lee, Kerry Bradley, David K. L. Peterson